RN Collins: Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29

  Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29 RN Collins | https://www.linkedin.com/in/rn-collins/ Abstract The week of April 18 through April 23, 2026 produced two distinct and legally consequential federal actions on controlled substances. On April 18, President Trump signed Executive […]